Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Products>This Product
  Products


GreenScreen HC

Product Image
Product Description

GreenScreen® HC is an accurate and fast in vitro human cell-based assay for the assessment of genotoxicity and cytotoxicity of compounds and mixtures.

The assay detects substances that are capable of causing damage to genetic material (DNA) within a cell. GreenScreen HC uses the human-derived, p53 competent, TK6 cell line to host a patented green fluorescent protein (GFP) reporter  system which exploits the proper regulation of the GADD45a gene.

Exposure to a genotoxic compound increases the expression of GADD45a and hence the induction of GFP production in the test strain. Simultaneous quantification of relative cell density or cell viability allows assessment of cytotoxicity.

•    Unique combination of high specificity and high sensitivity for genotoxicity
•    Detects all mechanistic classes of genotoxin (mutagens, aneugens and clastogens)
•    Most accurate genotoxicity screening test available
•    Simple, robust and fast protocol
•    Low sample requirement

The 96-well microplate format takes about 20 minutes to prepare and delivers results after a 48 hour incubation. A single microplate is used for the simultaneous testing of 4 compounds over 9 serial dilutions. The protocol is readily automated using standard laboratory equipment.

Product GreenScreen HC
Company Gentronix Ltd.
Price Request a quote
More Information View company product page
Catalog Number Unspecified
Quantity Unspecified
Company Logo

Gentronix Ltd.
BioHub at Alderley Park Alderley Edge Cheshire SK10 4TG United Kingdom

Tel: +44 (0)1625 238700
Fax: +44 (0)1625 238701
Email: info@gentronix.co.uk



Scientific News
Mass Spec Technology Drives Innovation Across the Biopharma Workflow
With greater resolving power, analytical speed, and accuracy, new mass spectrometry technology and techniques are infiltrating the biopharmaceuticals workflow.
One Step Closer to Precision Medicine for Chronic Lung Disease Sufferers
A study led by University of North Carolina at Chapel Hill, and National Jewish Health, has provided evidence of links between SNPs and known COPD blood protein biomarkers.
Charles River Acquires Agilux
Enhances Charles River’s early-stage capabilities in bioanalytical services.
Identified Compound Stops Cells Making Ribosomes
From study in yeast, researchers have identifed a compound that interferes with the assembly of ribosomes.
CES Score May Predict Response to Cancer Treatment
Researchers identify new type of biomarker that helps predict prognosis and response to several types of cancer treatment.
Treating Sepsis with Marine Mitochondria
Mitochondrial alternative oxidase from a marine animal combats bacterial sepsis.
New Therapeutic Target for Crohn’s Disease
A promising new target for drugs that treat IBD has been identified along with a possible biomarker for IBD severity.
Analysing 10,000 Cells Simultaneously
New techniquethat traps 10,000 cells on a single chip has potential for cancer screening for individuals.
Researchers Find Fungus-Fighting Compound
A compound has been identifed that blocks growth of a fungus responsible for lung infections and allergic reactions.
Peer Reviewed Study Demonstrates Mass Spec Technique
The peer reviewed study demonstrates MS workflow, TMTCalibrator workflow, which dramatically enhances detection of key early stage Alzheimer’s biomarkers.

SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
5,000+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!